Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of contextual and dispositional variables on protective behaviours in the face of imminent risk, as analysed using the virtual simulation of a tsunami.

Acta psychologica·2026
Same author

Introducing ISPA-AD: Interactive social problem-solving assessment for Alzheimer's disease.

Journal of neuropsychology·2026
Same author

Embodied Approach to Autobiographical Recall Disorders in Alzheimer's Disease.

Neuropsychology review·2025
Same author

Assessment of social cognition in patients with amyotrophic lateral sclerosis: protocol for a cross-sectional comparative study at Angers University Hospita.

BMJ open·2025
Same author

Effects of virtual reality mindfulness on cognition and well-being in ALS: A randomized trial protocol.

Contemporary clinical trials·2025
Same author

Social cognition in adults with neurofibromatosis type 1.

Journal of the International Neuropsychological Society : JINS·2024
Same journal

Semisynthesis of Mycothiazole Analogs having Distinct Bioactivity.

ACS medicinal chemistry letters·2026
Same journal

Investigation on the Cytotoxicity of Hydroxycinnamic and Hydroxybenzoic Acid-Based Natural Antioxidant Conjugated Terpyridine Analogues toward Triple-Negative Breast Cancer.

ACS medicinal chemistry letters·2026
Same journal

Beyond Neddylation Inhibition: X‑ray Structures Reveal Carbonic Anhydrase Isoform Selectivity of Pevonedistat.

ACS medicinal chemistry letters·2026
Same journal

Structure-Guided Discovery of Selective Polo-Like Kinase 3 Inhibitors.

ACS medicinal chemistry letters·2026
Same journal

Controlling Neuroplasticity Across Scales: Constrained Serotonergic Agonists, Neuroplastogens, and Adaptive Neuromodulation.

ACS medicinal chemistry letters·2026
Same journal

Degradation and Detection: Integrating BCL6 Targeted Protein Degradation with Biomarker-Guided BET Inhibition in Cancer.

ACS medicinal chemistry letters·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

Screening for GPCR Ligands Using Surface Plasmon Resonance.

Iva Navratilova1, Jérémy Besnard, Andrew L Hopkins

  • 1Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee , Dundee, DD1 5EH, United Kingdom.

ACS Medicinal Chemistry Letters
|July 19, 2011
PubMed
Summary
This summary is machine-generated.

A novel biosensor assay directly measures G-protein coupled receptor (GPCR)-ligand interactions. This label-free, cell-free method overcomes limitations of traditional assays, enabling efficient screening for new drug candidates like CCR5 ligands.

More Related Videos

Multimodal Analytical Platform on a Multiplexed Surface Plasmon Resonance Imaging Chip for the Analysis of Extracellular Vesicle Subsets
06:12

Multimodal Analytical Platform on a Multiplexed Surface Plasmon Resonance Imaging Chip for the Analysis of Extracellular Vesicle Subsets

Published on: March 17, 2023

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Related Experiment Videos

Last Updated: May 31, 2026

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

Multimodal Analytical Platform on a Multiplexed Surface Plasmon Resonance Imaging Chip for the Analysis of Extracellular Vesicle Subsets
06:12

Multimodal Analytical Platform on a Multiplexed Surface Plasmon Resonance Imaging Chip for the Analysis of Extracellular Vesicle Subsets

Published on: March 17, 2023

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Area of Science:

  • Pharmacology
  • Biochemistry
  • Drug Discovery

Background:

  • G-protein coupled receptors (GPCRs) are critical drug targets.
  • Current assays indirectly measure ligand binding through displacement or functional responses.
  • Challenges include allosteric modulation, probe dependence, and functional selectivity.

Purpose of the Study:

  • To develop a direct, label-free method for measuring GPCR-ligand interactions.
  • To overcome limitations of indirect and displacement-based screening assays.
  • To enable high-throughput screening for novel GPCR ligands.

Main Methods:

  • Developed a GPCR biosensor assay protocol.
  • Utilized label-free, cell-free screening.
  • Applied the method to solubilized, native GPCRs.

Main Results:

  • Successfully identified interactions of orthosteric and allosteric ligands.
  • Demonstrated the assay's ability to screen in a label-free, cell-free environment.
  • Exemplified the method by discovering novel ligands for the chemokine receptor CCR5.

Conclusions:

  • The GPCR biosensor assay provides a direct, label-free method for screening GPCR-ligand interactions.
  • This approach overcomes limitations of conventional assays.
  • It facilitates the discovery of novel ligands, including fragment-based leads for targets like CCR5.